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Background: Sex and gender can interact to contribute to differences in morbidity and mortality between men
and women. To detect such differences is an important issue for health policy planners when designing programmes
for the provision of healthcare services for the whole population. Our aim was to study differences between men and
women in the use of Primary Health Care (PHC) resources, taking into account age and morbidity burden.
Methods: An observational retrospective study was carried out using the information gathered in electronic medical
records from 79,809 adult patients who attended a PHC centre at least once in 2008. The ACG® System was used to
quantify the morbidity burden of patients. Poisson regression models were applied to analyse differences in the
number of visits to the PHC centre by men and women.
Results: Morbidity burden was significantly higher in women of all age groups. The gross number of visits to the PHC
centre was also higher for women in all age groups. However, when adjusting by age and morbidity burden, we did
not find a higher utilization by women compared to men. For high levels of morbidity burden, the attendance by men
was even significantly higher.
Conclusions: The overall higher use of PHC by women seems to be associated with their higher morbidity burden.
The interaction between biology and socially constructed roles could also underlie this higher use by women, and is
therefore an area that deserves further in-depth research.
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Women and men have biological differences (sex) that
may result in different health risks and needs. In addition
to biological factors, they also differ in social roles and
responsibilities (gender) that may have implications
for differences in health status and health behaviour,
as well as in access and use of health services [1].
Sex and gender can interact to contribute to differ-
ences in morbidity and mortality between men and
women. To detect such differences is an important
issue for health policy planners when designing pro-
grammes for the provision of healthcare services for
the whole population [2].
Many studies have analysed the combination of social
and biological causes of the differences in the health of
men and women [3-6]. Research undertaken in various* Correspondence: mtcarret@unizar.es
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unless otherwise stated.countries has often shown that the use of healthcare
services is higher among women [7-10], and also that
women generate a higher health cost [11]. However,
studies about these differences in utilization of services
mainly refer to patients with particular diseases [12,13],
to people of particular age ranges, such as the elderly
[14,15], or to different ethnic groups [16]. Very few arti-
cles analyse these differences in a broad age range or
take into account the morbidity burden [17,18].
In a context of important demographic and epidemio-
logical changes, multimorbidity is increasingly becoming
the rule among patients attending health services. The
morbidity burden is a key determinant for the utilization
of Primary Health Care (PHC) services and, therefore, is
a variable that should be included in studies examining
the use of such services [19]. Within PHC, any informa-
tion provided by such studies would be very useful when
designing programmes for the management of patientsal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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issue in many countries [19].
In general, studies about the health of men and women
are based on health surveys or on self-declared data.
Although these sources provide useful information [20],
self-appraisal of medical conditions may differ from the
real and objective health status of the individuals [21].
The aim of the present work was to analyse the differ-
ences in the number of visits to PHC between men and
women in the adult population, taking into account their
morbidity burden. The study was carried out using infor-
mation based on electronic medical records, which offer an
excellent opportunity to study the type and burden of mor-
bidity in population subgroups at individual level [22].
Methods
An observational retrospective study was carried out
using the information from electronic medical records
gathered at seven urban PHC Centres in Aragón, Spain.
The studied population included all patients over 14 years
of age who visited their PHC Centre at least once in 2008.
This represented around 60% of the total population
assigned to the participating PHC centres. Health Centres
were previously selected based on criteria related to the
quality of the collected information [23].
For each patient, information was obtained for the
following variables: demographic (age and sex); diag-
noses (based on the International Classification of
Primary Care ICPC-2); and utilization of PHC services.
This study was approved by the Ethics Committee of
Clinical Research of Aragón (CEICA, for its initials in
Spanish), which waived the need for written patient
consent because the study was based on the statistical
analysis of anonymous data.
The morbidity burden was measured using the num-
ber of Ambulatory Diagnosis Groups (ADG) provided by
the Johns Hopkins Adjusted Clinical Groups (ACG) Sys-
tem. This system assigns all ICPC-2 diagnoses registered
in the medical records during one year to one of 32
non-mutually exclusive clusters or ADGs according to
duration (acute, recurrent, or chronic), severity (e.g.,
minor and stable versus major and unstable), diagnostic
certainty (symptoms versus documented disease), aeti-
ology (infectious, injury, or other) and specialty care
involvement (e.g., medical, surgical, obstetric) of dis-
eases [24]. Thus, each ADG is a grouping of diagnoses
similar in terms of both clinical criteria and expected
need for healthcare resources. Just as individuals may
have multiple diagnosis codes, they may have multiple
ADGs (up to 32). To avoid using groups with very few
individuals, those with 7 or more ADGs were grouped
into one single category.
The utilization of resources was measured by the
number of visits to the PHC centre. A visit was definedas only face-to-face contact of the patient with the
health team (GP and/or nurse), when attending the PHC
centre.
To make managing age easier, 3 cut-off points were
established according to age distribution: closer value to
the mean minus 1 Standard Deviation (SD); the mean; and
the mean plus 1 SD. The resulting groups were the follow-
ing: ≤30 years; 31-50 years; 51-70 years; and >70 years.
The mean and 95% confidence intervals were calcu-
lated for continuous variables as well as the frequency
distribution for categorical variables; to find out the pos-
sible differences by gender on the number of visits to
the PHC centre the Mann-Whitney U test was carried
out, with the level of significance set at 5%. Moreover, to
analyse differences in the number of visits to the PHC
by men and women, adjusting by age and morbidity
burden, a multivariable Poisson regression model was
applied including a scale parameter to account for over-
dispersion of the outcome variable.
All statistical analyses were undertaken using the SPSS
program version 15.0.
Results
The study population included 79,089 patients over
14 years of age. There were 44,602 (56.4%) women in
the sample; in all age groups the number of women was
significantly higher than that of men.
Figure 1 shows that there was a higher percentage of
men with one and two ADGs. For a morbidity burden of
three ADGs, the percentage was similar for both men
and women. However, the percentage of women was
higher for a morbidity burden of four or more ADGs.
As seen in Figure 2, the morbidity burden increased
with age for both men and women. In all age groups,
the morbidity burden was significantly higher for women
compared to men (p < 0.05).
When looking at the total number of visits to PHC
centres by age group (Figure 3), women had a higher
attendance in all age groups (p < 0.05). However, when
analysing the global number of visits taking into account
the morbidity burden (Figure 4), figures were very simi-
lar in men and women for a burden below 4 ADGs. Yet,
above that level (4 or more ADGs) the number of visits
was higher for men (p < 0.05).
Table 1 shows the average number of visits to PHC for
the different age groups of men and women, taking into
account their morbidity burden. The number of visits to
PHC increased in all age groups with the number of
ADGs. In most age and morbidity burden groups, the
number of visits was similar between men and women.
For the second age group (31-50), and for those with a
morbidity burden of 6 and 7 or more ADGs, the number
of visits was significantly higher for men compared to


























Figure 1 Percentage of patients according to the number of ADGs.
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no longer significantly associated to PHC utilization
(IRR 0.997 95% CI 0.987-1.007) when age (IRR 1.005
95% CI 1.005-1.006) and morbidity burden (IRR 1.248
95% CI 1.245-1.252) were considered.
Discussion
This study shows that women have a significantly higher
burden of morbidity than men in all age groups. Our over-
all results also indicate that women visit PHC centres more
frequently than men. However, when those figures were
analysed by age group and morbidity burden, and adjusted
accordingly, we did not find a higher utilization of PHC ser-
vices by women compared to men. Indeed, although the
multivariable regression model did not show any significant
association between sex and PHC service use, for high
levels of morbidity burden, and hence increased clinical
complexity, the attendance by men was significantly higher.Figure 2 Average number of ADGs and 95% CI by age group.Regarding morbidity burden, Uijen and van de Lisdonk
[25] and Salisbury et al. [26] also found that women
had a higher morbidity burden than men, although in
the latter study the differences were not as high as
ours, even though they also used the ACG System for
measuring morbidity. Our results slightly differ from
those published by Fortin et al. [27] in a study in
Canada showing a higher morbidity burden for men
than for women, but only for a particular age group
and using a different system for quantifying the num-
ber of health problems. In Ireland, a more recent study
found that multimorbidity was not affected by gender
[28], but the study was restricted to people over
50 years of age. The higher morbidity burden in
women is frequently explained by the difference in
biology and gender; the interaction between biology
and socially constructed roles is not often taken into
account [1].
Figure 3 Average number of annual visits and 95% CI by age group.
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visits clearly increased with morbidity burden and that
women went significantly more often to PHC centres
than men. The higher attendance by women has been
previously reported [7-11] and, in general, a higher use
of health resources by women has been suggested
[10,15,16,29,30]. Yet, those studies did not take into con-
sideration that, in general, women have a greater mor-
bidity burden than men, which seems to explain these
differences in PHC use.
The results of an interesting recent study by Wang et al
[18] can be compared to those of our study. Although they
found that crude primary consultation rate -every consult-
ation between a health professional and a patient- was
32% lower in men than women, when underlying morbid-
ities were comparable in men and women they reported
that consultation rates were similar.
In general, the higher utilization of health services by
women found in many studies has been associated to aFigure 4 Average number of annual visits and 95% CI by morbidity bworse perception of their own health [6,8]. Social rea-
sons, their role as carer of the family health or having a
protective attitude towards disease, could also be sug-
gested. Our data show that the morbidity burden of
women is higher than that of men, i.e. although women
may have a worse perception of their health, it is clear
that they objectively have a worse health than men.
Yet, in our study, when considering morbidity burden,
differences in utilization of PHC services were not
significantly higher for women and in some groups
even higher for men, as in the group of middle-aged
very ill patients. This could be explained because for
women looking after the health of the rest of the family
may be at the expense of their own health. Another
reason could be that in many cases women are able to
use more effective coping strategies, such as seeking
social support, in particular that from other females in
response to stress [31]. Therefore, the need for profes-
sional health consultation may be reduced for certainurden.
Table 1 Average number of annual visits and 95% CI of men and women by age group and morbidity burden
≤30 Years 31-50 Years 51-70 Years >70 Years
No ADG Male (n = 7173) Female (n = 8732) Male (n = 11314) Female (n = 14159) Male (n = 10364) Female (n = 12973) Male (n = 5636) Female (n = 8738)
% No visits % No visits % No visits % No visits % No visits % No visits % No visits % No visits
1 37.6 2.53* 24.4 2.61* 34.3 2.98* 20.5 2.94* 19.4 4.93 12.9 4.84 10.4 7.30 8.0 7.39
(2.43 -2.63) (2.49 –2.73) (2.87 – 3.09) (2.82 – 3.06) (4.70 – 5.17) (4.59 – 5.09) (6.77–7.83) (6.86–7.92)
2 29 4.02 24.5 3.99 27.1 4.69* 23.1 4.76* 23.2 7.56 17.7 7.50 17.0 9.69 13.7 9.62
(3.87 -4.18) (3.84 –4.13) (4.52 – 4.86) (4.61 – 4.92) (7.28 – 7.85) (7.24 – 7.75) (9.22 –10.15) (9.16–10.08)
3 17.6 5.69 19.5 5.53 17.5 6.70 19.5 6.63 19.3 9.53* 19.0 9.68* 18.5 12.06 16.3 12.29
(5.41 -5.97) (5.32 –5.73) (6.42 – 6.97) (6.41 – 6.86) (9.19 – 9.87) (9.40 –9.97) (11.58 -12.55) (11.75–12.83)
4 8.9 7.55 13.8 7.17 10.4 8.63 14.2 8.64 15.6 12.13 16.6 11.71 17.5 14.21 16.4 13.84
(7.04 -8.06) (6.88 –7.47) (8.18 – 9.07) (8.35 – 8.94) (11.65-12.60) (11.38 –12.03) (13.61 -14.08) (13.37–14.31)
5 3.9 9.72 8.3 8.98 5.7 10.98 9.9 10.34 10.1 14.52 12.6 13.77 13.7 16.50 14.8 16.64
(8.73 -10.70) (8.51 –9.45) (10.24-11.72) (9.93 – 10.75) (13.86-15.19) (13.34 –14.20) (15.64 –17.36) (16.01–17.26)
6 1.8 11.78 5.0 10.80 2.7 13.41* 6.2 11.79* 6.4 16.70 8.5 15.82 9.9 19.14 11.6 18.97
(10.49 -13.07) (10.14 –11.46) (12.28-14.53) (11.23 –12.35) (15.87-17.53) (15.27 –16.37) (18.12 -20.16) (18.14–19.79)
≥7 1.2 14.75 4.4 13.97 2.3 19.64* 6.7 16.70* 6.2 21.29 12.6 20.43 13.1 23.06 19.2 23.01
(12.63 -16.87) (13.13 –14.82) (17.84-21.45) (15.92-17.48) (20.32-22.26) (19.84 –21.02) (22.01 -24.11) (22.34–23.68)
n: number of individuals; in brackets 95% CI.
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likely than men to visit a GP when a problem is serious;
a close relationship between consultation behaviour and
severity of the problem has been found in women but
not in men [32].
Our work has two main strengths. First, the use of
data gathered from electronic medical records has been
suggested to be the most appropriate way for undertak-
ing this type of study [28]. Second, the ADG system has
been used to measure the morbidity burden. This system
is considered to overcome medical coding problems and
to allow an appropriate evaluation of the morbidity bur-
den of individuals from PHC [33].
The possible limitations of this study are that, being
based on medical records, it could be underestimating
the morbidity burden of the population, as there could
be patients who do not visit the PHC centres and, there-
fore, would not be identified [26]. Moreover, the rela-
tionship between morbidity burden and the number of
visits may carry the risk of creating a vicious circle, in
which people going more often to the centres are more
likely to have more diseases diagnosed. Nevertheless,
electronic medical records, as compared to administra-
tive claims, offer greater accuracy of patients’ morbidity
burden, because there is no reimbursement linked to
data registration. Thus, new episodes of care are not
necessarily generated for every visit to the GP. Finally, in
this study the socioeconomic characteristics of the popu-
lation have not been analysed, a factor considered to be
important regarding the morbidity burden and the use
of health services.
Conclusions
The overall higher use of PHC by women seems to be
associated with their higher morbidity burden. The inter-
action between biology and socially constructed roles
could also underlie this higher use by women, and is
therefore an area that deserves further in-depth research.
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